Net Income Common - E-Therapeutics PLC (LSE:ETX) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 9.4 GBX -3.59%

Updated:

E-Therapeutics PLC
Net Income (Common)

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

E-Therapeutics PLC
Net Income (Common) Peer Comparison

CNTA

AUTL

BCYC

IMCR

GNS

Company		Net Income (Common)	CAGR 3Y	CAGR 5Y	CAGR 10Y
	E-Therapeutics PLC LSE:ETX	Net Income (Common) -£8.3m	CAGR 3-Years -52%	CAGR 5-Years -9%	CAGR 10-Years -7%
	Centessa Pharmaceuticals PLC NASDAQ:CNTA	Net Income (Common) -$151.1m	CAGR 3-Years -142%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Autolus Therapeutics PLC NASDAQ:AUTL	Net Income (Common) -$208.4m	CAGR 3-Years -14%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Bicycle Therapeutics PLC NASDAQ:BCYC	Net Income (Common) -$168.2m	CAGR 3-Years -44%	CAGR 5-Years -45%	CAGR 10-Years N/A
	Immunocore Holdings PLC NASDAQ:IMCR	Net Income (Common) -£55.3m	CAGR 3-Years 9%	CAGR 5-Years 5%	CAGR 10-Years N/A
	Genus PLC LSE:GNS	Net Income (Common) £33.4m	CAGR 3-Years -8%	CAGR 5-Years N/A	CAGR 10-Years 3%

See Also

Based on the financial report for Jan 31, 2023, E-Therapeutics PLC's Net Income (Common) amounts to -8.3m GBP.

Over the last year, the Net Income (Common) growth was -3%. The average annual Net Income (Common) growth rates for E-Therapeutics PLC have been -52% over the past three years , -9% over the past five years , and -7% over the past ten years .

Join more than 134,200+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.